STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 75 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q1 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $9,159,000 | -6.7% | 4,489,687 | +35.8% | 4.17% | -18.8% |
| Q2 2021 | $9,818,000 | +698.2% | 3,305,617 | +641.7% | 5.13% | +673.2% |
| Q1 2021 | $1,230,000 | -62.5% | 445,701 | -67.0% | 0.66% | -73.6% |
| Q4 2020 | $3,281,000 | -18.8% | 1,350,000 | -29.9% | 2.51% | -40.3% |
| Q3 2020 | $4,042,000 | +347.6% | 1,924,956 | +345.7% | 4.20% | +568.5% |
| Q4 2019 | $903,000 | +77.8% | 431,853 | +166.2% | 0.63% | +79.7% |
| Q2 2019 | $508,000 | -45.5% | 162,244 | -13.3% | 0.35% | -34.7% |
| Q1 2019 | $932,000 | -62.7% | 187,074 | -45.7% | 0.54% | -64.2% |
| Q4 2017 | $2,496,000 | – | 344,282 | – | 1.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,612,065 | $12,497,000 | 13.66% |
| Ikarian Capital, LLC | 3,392,787 | $6,412,000 | 0.48% |
| NEA Management Company, LLC | 4,141,308 | $7,827,000 | 0.41% |
| Alambic Investment Management, L.P. | 61,764 | $117,000 | 0.28% |
| KNOTT DAVID M | 181,800 | $344,000 | 0.22% |
| 683 Capital Management, LLC | 917,942 | $1,736,000 | 0.10% |
| Hudson Bay Capital Management LP | 1,409,419 | $2,664,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 388,309 | $734,000 | 0.06% |
| &PARTNERS | 15,000 | $28,000 | 0.04% |
| Diversified Trust Co | 198,534 | $375,000 | 0.02% |